D335

Tumorvirus-spez. Vakzinierungsstrategie
IDI:(DE-He78)D335-20160331

Recent Publications

All known publications ...
Download: BibTeX | EndNote XML,  Text | RIS | 

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Real-time genome imaging of host interactions in adeno-associated virus genome release
iScience 28(6), 112624 () [10.1016/j.isci.2025.112624]  GO DBCoverage BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article (Editorial)  ;  ;
Editorial: Papillomaviruses, immunity, and tumour development.
Frontiers in Cellular and Infection Microbiology 15, 1599910 () [10.3389/fcimb.2025.1599910]  GO DBCoverage   Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;
Die Entwicklung eines neuen Impfstoffs gegen humane Papillomviren (HPV) im akademischen Umfeld – TEIL 2 / Papillomavirus Impfstoff PANHPVAX:First-in-Human – eine neue Herausforderung
PM/QM - Fachzeitschrift für pharmazeutische Medizin und Qualitätsmanagement - nur für Mitglieder 1, 46-54 ()  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;
Mechanistic insights into HPV-positivity in non-smokers and HPV-negativity in smokers with head and neck cancer.
Frontiers in oncology 14, 1484319 () [10.3389/fonc.2024.1484319]  GO DBCoverage   Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;
Die Entwicklung eines neuen Impfstoffs gegen humane Papillomviren (HPV) im akademischen Umfeld – TEIL 1 Papillomavirus Impfstoff PANHPVAX: Herausfordernde Schritte von der Idee zur Erstanwendungsstudie
PM/QM - Fachzeitschrift für pharmazeutische Medizin und Qualitätsmanagement - nur für Mitglieder 26(3), 4-11 ()  GO BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58.
npj vaccines 9(1), 165 () [10.1038/s41541-024-00949-2]  GO DBCoverage   Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study.
npj vaccines 9(1), 146 () [10.1038/s41541-024-00941-w]  GO DBCoverage  Download fulltext Files BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;
Quantification of HPV16 E7 Oncoproteins in Urine Specimens from Women with Cervical Intraepithelial Neoplasia.
Microorganisms 12(6), 1205 () [10.3390/microorganisms12061205]  GO DBCoverage  Download fulltext Files  Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity.
npj vaccines 9(1), 119 () [10.1038/s41541-024-00914-z]  GO DBCoverage  Download fulltext Files BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Ovine papillomavirus type 3 virus-like particle-based tools for diagnosis and detection of infection.
Vaccine 42(22), 126033 () [10.1016/j.vaccine.2024.06.001]  GO  Download fulltext Files BibTeX | EndNote: XML, Text | RIS

All known publications ...
Download: BibTeX | EndNote XML,  Text | RIS | 


 Record created 2024-02-14, last modified 2024-02-15



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)